192 related articles for article (PubMed ID: 31996771)
1. Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren's syndrome murine model.
Fu R; Guo H; Janga S; Choi M; Klinngam W; Edman MC; Hamm-Alvarez SF
Sci Rep; 2020 Jan; 10(1):1455. PubMed ID: 31996771
[TBL] [Abstract][Full Text] [Related]
2. Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.
Fu R; Edman MC; Hamm-Alvarez SF
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562815
[TBL] [Abstract][Full Text] [Related]
3. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
Meng Z; Edman MC; Hsueh PY; Chen CY; Klinngam W; Tolmachova T; Okamoto CT; Hamm-Alvarez SF
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C942-54. PubMed ID: 27076615
[TBL] [Abstract][Full Text] [Related]
4. Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.
Fu R; Janga S; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2021 Oct; 211():108760. PubMed ID: 34487726
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.
Janga SR; Shah M; Ju Y; Meng Z; Edman MC; Hamm-Alvarez SF
Biomarkers; 2019 Feb; 24(1):91-102. PubMed ID: 30126300
[TBL] [Abstract][Full Text] [Related]
8. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
Li X; Wu K; Edman M; Schenke-Layland K; MacVeigh-Aloni M; Janga SR; Schulz B; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5019-29. PubMed ID: 20463324
[TBL] [Abstract][Full Text] [Related]
11. Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients.
Edman MC; Janga SR; Meng Z; Bechtold M; Chen AF; Kim C; Naman L; Sarma A; Teekappanavar N; Kim AY; Madrigal S; Singh S; Ortiz E; Christianakis S; Arkfeld DG; Mack WJ; Heur M; Stohl W; Hamm-Alvarez SF
Sci Rep; 2018 Jul; 8(1):11044. PubMed ID: 30038391
[TBL] [Abstract][Full Text] [Related]
12. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
Ju Y; Janga SR; Klinngam W; MacKay JA; Hawley D; Zoukhri D; Edman MC; Hamm-Alvarez SF
Exp Eye Res; 2018 Nov; 176():243-251. PubMed ID: 30201519
[TBL] [Abstract][Full Text] [Related]
13. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
14. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
[TBL] [Abstract][Full Text] [Related]
15. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
[TBL] [Abstract][Full Text] [Related]
16. A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.
Shah M; Edman MC; Janga SR; Shi P; Dhandhukia J; Liu S; Louie SG; Rodgers K; Mackay JA; Hamm-Alvarez SF
J Control Release; 2013 Nov; 171(3):269-79. PubMed ID: 23892265
[TBL] [Abstract][Full Text] [Related]
17. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
18. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Seo Y; Kim HS; Kang I; Choi SW; Shin TH; Shin JH; Lee BC; Lee JY; Kim JJ; Kook MG; Kang KS
Glia; 2016 Dec; 64(12):2291-2305. PubMed ID: 27687148
[TBL] [Abstract][Full Text] [Related]
20. Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.
Ju Y; Edman MC; Guo H; Janga SR; Peddi S; Louie SG; Junge JA; MacKay JA; Hamm-Alvarez SF
Biomacromolecules; 2021 Mar; 22(3):1102-1114. PubMed ID: 33356170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
